A 28-year-old woman presents with dysuria, frequency, and urgency for 3 days. She has no fever or flank pain. Urine dipstick shows nitrites and leukocyte esterase positive. She is allergic to penicillin (rash). Urine culture is pending. Which of the following is the most appropriate empirical antimicrobial choice for uncomplicated acute cystitis in this patient?

Explanation

## Clinical Context This is a case of uncomplicated acute cystitis (lower UTI) in a non-pregnant woman with penicillin allergy. The patient requires a first-line agent that is safe, effective, and appropriate for short-course therapy. ## Why Nitrofurantoin is Correct **High-Yield:** Nitrofurantoin 100 mg (modified-release) twice daily for 5 days is a first-line agent for uncomplicated acute cystitis per IDSA guidelines (Gupta et al., CID 2011) and is widely recommended in current practice due to its excellent urinary concentrations, low systemic absorption, and minimal impact on bowel flora. **Key Point:** TMP-SMX resistance among uropathogens (primarily *E. coli*) exceeds 20% in many regions including India and parts of the US, which is the threshold above which empirical use is discouraged by IDSA guidelines. Nitrofurantoin retains >95% susceptibility against common uropathogens and is therefore preferred as empirical therapy when local TMP-SMX resistance is uncertain or high. **Clinical Pearl:** Nitrofurantoin is contraindicated in patients with renal impairment (eGFR <30 mL/min) and in late pregnancy (≥38 weeks), but is safe and effective in otherwise healthy non-pregnant women with uncomplicated cystitis. ## Mechanism of Action | Agent | Target | Effect | |-------|--------|--------| | Nitrofurantoin | Multiple bacterial enzymes (DNA, ribosomes, cell wall synthesis) | Bactericidal via reactive intermediates | | TMP-SMX | Sequential folate pathway (DHFR + DHPS) | Bactericidal synergy — but resistance limits empirical use | ## Comparison with Alternatives | Agent | Role in UTI | Limitation in This Case | |-------|-------------|------------------------| | **Nitrofurantoin** | **First-line uncomplicated UTI** | **None — ideal empirical choice** | | TMP-SMX | First-line only where local resistance <20% | Rising resistance (>20% in many regions) limits empirical use | | Cephalexin | β-lactam; second-line option | Penicillin cross-reactivity ~1–3% risk; not preferred empirically | | Fluoroquinolone | Reserved for complicated UTI/pyelonephritis | Overuse drives resistance; IDSA recommends against first-line use for simple cystitis | **Key Point:** Per IDSA 2011 guidelines (KD Tripathi, Essentials of Medical Pharmacology, 9th ed.), fluoroquinolones should be reserved for complicated infections or pyelonephritis. Nitrofurantoin is the preferred empirical first-line agent for uncomplicated cystitis when TMP-SMX resistance cannot be excluded.